Literature DB >> 25460564

Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child-Pugh Class, and Effects of Antibiotics.

Puneeta Tandon1, Juan G Abraldes2, Adam Keough2, Ravin Bastiampillai2, Saumya Jayakumar2, Michelle Carbonneau2, Eric Wong2, Dina Kao2, Vince G Bain2, Mang Ma2.   

Abstract

BACKGROUND & AIMS: Antibiotics frequently are overused and are associated with serious adverse events in patients with cirrhosis. However, these drugs are recommended for all patients presenting with acute variceal hemorrhage (AVH). We investigated whether patients should be stratified for antibiotic prophylaxis based on Child-Pugh scores, to estimate risks of bacterial infection, rebleeding, and mortality, and whether antibiotics have equal effects on patients of all Child-Pugh classes. We performed a sensitivity analysis using model for end-stage liver disease (MELD) scores.
METHODS: In a retrospective study, we analyzed data from 381 adult patients with cirrhosis and AVH (70% men; mean age, 56 y), admitted from 2000 through 2009 to 2 tertiary care hospitals in Edmonton, Alberta, Canada. We excluded patients with bacterial infection on the day of AVH. The association between antibiotic prophylaxis and outcomes was adjusted by liver disease severity and by a propensity score.
RESULTS: The patients included in the study had mean MELD scores of 16, and 54% received antibiotic prophylaxis. Overall, antibiotic therapy was associated with lower risks of infection (adjusted odds ratio, 0.37; 95% confidence interval, 0.91-0.74) and mortality (adjusted odds ratio, 0.63; 95% confidence interval, 0.31-1.29). Among patients categorized as Child-Pugh class A given antibiotics, only 2% developed infections and the mortality rate was 0.4%. Among patients categorized as Child-Pugh class B given antibiotics, 6% developed infections, compared with 14% of patients who did not receive antibiotics; antibiotics did not affect mortality. Administration of antibiotics to patients categorized as Child-Pugh class C reduced infections and mortality by approximately 50%, compared with patients who did not receive antibiotics. MELD scores were not as useful as Child-Pugh class in identifying patients at risk for infection.
CONCLUSIONS: Based on a retrospective analysis of patients with cirrhosis and AVH, those categorized as Child-Pugh class A had lower rates of bacterial infection and lower mortality rates in the absence of antibiotic prophylaxis than patients categorized as classes B or C. The recommendation for routine antibiotic prophylaxis for this subgroup requires further evaluation.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced Liver Disease; Antibiotic Resistance; Bleeding; Stratification

Mesh:

Substances:

Year:  2014        PMID: 25460564     DOI: 10.1016/j.cgh.2014.11.019

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

Review 1.  Pathophysiology and Management of Variceal Bleeding.

Authors:  Saleh A Alqahtani; Sunguk Jang
Journal:  Drugs       Date:  2021-03-12       Impact factor: 9.546

2.  Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study.

Authors:  Brett E Fortune; Guadalupe Garcia-Tsao; Maria Ciarleglio; Yanhong Deng; Michael B Fallon; Samuel Sigal; Naga P Chalasani; Joseph K Lim; Adrian Reuben; Hugo E Vargas; Gary Abrams; Michele D Lewis; Tarek Hassanein; James F Trotter; Arun J Sanyal; Kimberly L Beavers; Daniel Ganger; Paul J Thuluvath; Norman D Grace; Roberto J Groszmann
Journal:  J Clin Gastroenterol       Date:  2017 May/Jun       Impact factor: 3.062

Review 3.  Acute kidney injury: prediction, prognostication and optimisation for liver transplant.

Authors:  Nishita Jagarlamudi; Florence Wong
Journal:  Hepatol Int       Date:  2020-03-03       Impact factor: 6.047

4.  Reply to Risk Stratification in Acute Variceal Bleeding: Child-Pugh Versus Model for End-stage Liver Disease.

Authors:  Brett E Fortune; Maria Ciarleglio; Yanhong Deng; Guadalupe Garcia-Tsao
Journal:  J Clin Gastroenterol       Date:  2019-04       Impact factor: 3.062

Review 5.  Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem.

Authors:  Guadalupe Garcia-Tsao; Jaime Bosch
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 11.382

Review 6.  Management of Portal Hypertension.

Authors:  Anand V Kulkarni; Atoosa Rabiee; Arpan Mohanty
Journal:  J Clin Exp Hepatol       Date:  2022-03-21

Review 7.  Pharmacologic prevention of variceal bleeding and rebleeding.

Authors:  Anna Baiges; Virginia Hernández-Gea; Jaime Bosch
Journal:  Hepatol Int       Date:  2017-12-05       Impact factor: 6.047

8.  Acute Variceal Bleed in Cirrhosis is Associated With Reversible Changes in Tight Junction Protein Expression in the Intestine: A Proof-of-Concept Study.

Authors:  Kanav Kaushal; Vipin Gupta; Pooja Goswami; Samagra Agarwal; Sanchit Sharma; Prasenjit Das; Rajni Yadav; Abhinav Anand; Ujjwal Sonika; Deepak Gunjan; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-04-03

9.  Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study.

Authors:  Gang Qin; Jian-Guo Shao; Yong-Chang Zhu; Ai-Dong Xu; Jian-Hua Yao; Xu-Lin Wang; Yin-Kun Qian; Hua-Yu Wang; Yi Shen; Peng Lu; Lu-Jun Wang
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

Review 10.  Variceal bleeding in cirrhotic patients.

Authors:  Maxime Mallet; Marika Rudler; Dominique Thabut
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.